Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin Therapy

Patent No. EP3815684 (titled "Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin Therapy") was filed by Amarin Pharmaceuticals Ireland on Jun 28, 2013. The application was issued on Sep 4, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ELKINGTON AND FIFEMay 9, 2025ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3815684

AMARIN PHARMACEUTICALS IRELAND
Application Number
EP20201864A
Filing Date
Jun 28, 2013
Status
Granted And Under Opposition
Aug 2, 2024
Publication Date
Sep 4, 2024